Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Spectral enrolled 13+ patients per month!
View:
Post by hmmmmmmmm on Apr 14, 2023 2:40am

Spectral enrolled 13+ patients per month!

As Seto and Kellum compared the current Tigris enrollment to that of Euphrates- I thought I'd take a look back. Here are some of Spectral's enrollment announcements from 2013 to 2016. (links below)

On July 13 2013 Euphrates had 156 patients enrolled. By April 11 of 2014 it was 271.

So in 9 months Dr Walker and Co. enrolled 115 patients- almost 13 per month

By Jan 25 2015 they had 400 patients enrolled.

So in that 9.5 months 129 patients were added. Just over 13 1/2  per month. 

On June 20 2016 they announced the trial had completed enrollment. Not clear if that was the date of the last patient- but if it was the final 46 patients took them18 months - or only 2.5 per month.

So at one time the Spectral enrolled 13+ patients per month. 

Most shareholders would see that as a pretty amazing difference from the almost 2 per month we've seen over 3 years with Tigris.

Seto and Kellum's version of "doing better" seems to be based on the idea that Euphrates used more sites. 

So why didn't they start Tigris with more sites! It's some pretty easy math. Spectral had their"known" average per month per site. Maybe they could have figured out that if they had only 1/3  as many sites it would take 3 times as long...

And we wonder why we're in the .20s



2013

https://www.newswire.ca/news-releases/spectral-provides-update-on-its-euphrates-trial-512764141.html

 

2014 

https://www.obio.ca/obio-backup/obio1/2014/04/spectral-updates-status-of-euphrates-trial

 

2015

https://s27.q4cdn.com/906368049/files/January-25-2015_T.EDT_Marckx.pdf

 

2016

https://sports.yahoo.com/news/spectral-medical-announces-completion-enrolment-120000396.html

Comment by oilandgasman on Apr 14, 2023 10:11am
dead money for the next 3 years.
Comment by mercedesman on Apr 14, 2023 12:29pm
Can't argue with facts  Obviously there are many factors influencing the speed of enrolment. Some within their control, some not.  I didn't hear a lot of discussion about why it has taken this long to plot a new course in the face of said obstacles   This should  be factored into PSU granting process IMO 
Comment by BayStreetWild on Apr 14, 2023 12:46pm
Race is on between Trigon Metals and Spectral. more or less the same price today. Let's see where we sit in 3 months from now. 
Comment by BayStreetWild on Apr 28, 2023 7:11pm
Already winning
Comment by Accountprince on Apr 29, 2023 11:44am
Where do you get the info that 13+ enrolled per month BSW?  Haven't seen anything about this anywhere.
Comment by mercedesman on May 16, 2023 2:29pm
One month review/follow-up. Trigon down 15% (.26 to .22) and  Spectral up 20%  (.28 to .335) !!! Horrible pair trade idea ! But don't lose hope, maybe it'll get better.  Nevertheless the key time for a full & fair review will be in 12 months and 24 months time. MM
Comment by BayStreetWild on May 16, 2023 3:52pm
Can't argue with loading up options at .255 and then letting the share price go. When you're right you're right. Overall I'm in trigon at 16 and out EDT at 45 last year. So far so good but maybe you're right and this will be the ultimate play for you. As for me I won't put money here. For better or worse.
Comment by daviking on Aug 04, 2023 1:09pm
How's Trigon doing, these days, BSW? You have said, $0.75 for TM by Jan 2024! Still counting on that?
Comment by daviking on Aug 05, 2023 2:11pm
Here we are a bit more than 3 months later: April 14, 2023 Trigon - 0.25 Spectral - 0.28 Aug. 4 Trigon - 0.18 (down ~25%) Spectral - 0.33 (up ~17%) You also said, $0.75 for TM by Jan 2024! Still counting on that?
Comment by oilandgasman on Aug 05, 2023 2:34pm
It's been .33 cents for 15 years on and off..... .33?  LOL Is this meant to make me feel better about what looks like a bad investment?
Comment by daviking on Aug 05, 2023 7:40pm
You talking' to me? Why?
Comment by hmmmmmmmm on Apr 14, 2023 1:19pm
Yes, it took them years, tens of millions of sharholder's investments, and absurd dillution to figure out what could have been worked out on the back of a napkin. As they knew "Actual Enrollment Rate Averages" from the EUPHRATES trial it would have been pretty simple to then adjust the number of sites and see the effect on the timeline. So many times they've have told us how ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities